November is Diabetes Awareness Month; it’s a disease that affects millions of people across the United States – both with ...

Zucara Therapeutics Inc., a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that ...

Sanofi's Chief Digital Officer Emmanuel Frenehard had a thought that he just couldn't shake: how can Sanofi extend the ...

Rob Koremans, CEO of Italian pharmaceutical company Recordati, weighs in on the company's purchase of Sanofi's rare immune ...

Dr. Reddy's Laboratories Ltd.(down 2.87 per cent), Biocon Ltd.(down 2.77 per cent), Sanofi India Ltd.(down 1.64 per cent), ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

Some school districts, including MSCS, have what's called a self-funded health plan. That means the employer pays for ...

The District 60 Board of Education unanimously approved a resolution hiring the Frantz Law Group Tuesday at the Lincoln Center administration building in Waukegan to help it recoup some of the ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

London-listed GSK Plc and France’s Sanofi SA saw similar declines, with Deutsche Bank analyst Emmanuel Papadakis cutting his ...